Supernus Pharmaceuticals announced it will release its third quarter 2026 financial and business results after the market closes on Thursday, October 29, 2026. This filing serves as a procedural scheduling announcement and does not contain financial data or updated guidance for the period.
Key Highlights
- Third quarter 2026 earnings release is scheduled for October 29, 2026, post-market.
- Management will host a conference call and live webcast to discuss results at 4:30 p.m. ET.
- The report will cover the three-month fiscal period ended September 30, 2026.